Pharmaceutical Investing Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
Pharmaceutical Investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
Pharmaceutical Investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
